Related Experiment Video
Updated: Aug 12, 2026
08:37
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Regulatory T cells and inflammatory bowel disease
1INSERM U343, Hôpital de l'Archet, Route de Saint Antoine de Ginestières, 06200 Nice, France. groux@unice.fr
Immunology Today
|September 29, 1999
Summary
Interleukin 10 drives regulatory T cells that suppress immune responses to gut antigens. A lack of these cells may contribute to inflammatory bowel disease development.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Interleukin 10 (IL-10) is recognized as a key cytokine in immune regulation.
- Regulatory T cells (Tregs) play a critical role in maintaining immune homeostasis.
Purpose of the Study:
- To investigate the function of a novel subset of IL-10-dependent regulatory T cells.
- To explore the involvement of these regulatory T cells in immune responses to enteric antigens.
- To examine the potential role of these cells in the pathogenesis of inflammatory bowel disease (IBD).
Main Methods:
- Analysis of T cell differentiation and function.
- Studies involving immune responses to antigens in the gut.
- Examination of cellular deficiencies and their link to disease.
Main Results:
- Identification of a novel subset of regulatory T cells differentiated by IL-10.
- Demonstration of the role of these cells in suppressing immune responses to enteric antigens.
- Hypothesis that a deficiency in these cells may be implicated in IBD pathogenesis.
Conclusions:
- Interleukin 10 is crucial for the differentiation of a specific subset of immune-suppressive regulatory T cells.
- These regulatory T cells are vital for controlling immune reactions to gut-derived antigens.
- Dysfunction or deficiency of these IL-10-driven regulatory T cells presents a potential mechanism underlying inflammatory bowel disease.
Related Concept Videos
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...